Editorial: Role of complement activation in kidney diseases

Frontiers in Medicine

Medicine

Takashi Oda¹  Toshihiro Sawai² 

[1] Department of Nephrology and Blood Purification, Kidney Disease Center, Tokyo Medical University Hachioji Medical Center, Hachioji, Japan;Department of Pediatrics, Shiga University of Medical Science, Otsu, Japan;

关键词: complement activation;    alternative pathway;    classical pathway;    lectin pathway;    kidney diseases;    eculizumab;    avacopan;   

DOI  :  10.3389/fmed.2023.1297938

 received in 2023-09-20, accepted in 2023-10-06,  发布年份 2023

来源: Frontiers

【 授权许可】

Unknown   
Copyright © 2023 Oda and Sawai.